Comparison of acute skin reaction following morning versus late afternoon radiotherapy in patients with breast cancer who have undergone curative surgical resection

Journal of Radiation Research

Volumn 55, Issue 3, 2014, Pages 553-558

  Noh, Jae Myoung ^a   Choi, Doo Ho ^a   Park, Hyojung ^a   Huh, Seung Jae ^a   Park, Won ^a   Seol, Seung Won ^a   Jeong, Bae Kwon ^b   Nam, Seok Jin ^a   Lee, Jeong Eon ^a   Kil, Won Ho ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Gyeongsang National University   (South Korea)

Author keywords

breast cancer; circadian rhythm; radiation induced dermatitis; radiotherapy

Indexed keywords

DISEASES; ONCOLOGY; PATHOLOGY;

ADJUVANT RADIOTHERAPY; BREAST CANCER; CIRCADIAN RHYTHMS; FOLLOW UP; RADIATION-INDUCED; RADIATION-INDUCED DERMATITIS; SKIN REACTION; SURGICAL RESECTION; TREATMENT GROUP; TREATMENT OUTCOMES;

RADIOTHERAPY;

ADJUVANT THERAPY; ADULT; AGED; BREAST NEOPLASMS; CIRCADIAN RHYTHM; COMORBIDITY; COMPARATIVE STUDY; EPIDEMIOLOGY; FEMALE; HUMAN; INCIDENCE; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; RADIATION DERMATITIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; SKIN SURGERY; SOUTH KOREA; SURVIVAL RATE; TIME; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CAUSALITY; CIRCADIAN RHYTHM; COMORBIDITY; DERMATOLOGIC SURGICAL PROCEDURES; FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; RADIODERMATITIS; RADIOTHERAPY, ADJUVANT; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84900838750     PISSN: 04493060     EISSN: 13499157     Source Type: Journal    
DOI: 10.1093/jrr/rrt141     Document Type: Article

References (31)

1. Levi F. Circadian chronotherapy for human cancers. Lancet Oncol 2001; 2: 307-15.
2. Reppert SM, Weaver DR. Molecular analysis of mammalian circadian rhythms. Annu Rev Physiol 2001; 63: 647-76.
3. Reppert SM, Weaver DR. Coordination of circadian timing in mammals. Nature 2002; 418: 935-41.
4. Hastings MH, Reddy AB, Maywood ES. A clockwork web: circadian timing in brain and periphery, in health and disease. Nat Rev Neurosci 2003; 4: 649-61.
5. Matsuo T, Yamaguchi S, Mitsui S et al. Control mechanism of the circadian clock for timing of cell division in vivo. Science 2003; 302: 255-9.
6. Fu L, Pelicano H, Liu J et al. The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell 2002; 111: 41-50.
7. Mormont MC, Levi F. Cancer chronotherapy: principles, applications, and perspectives. Cancer 2003; 97: 155-69.
8. Levi F. From circadian rhythms to cancer chronotherapeutics. Chronobiol Int 2002; 19: 1-19.
9. Granda TG, Filipski E, D'Attino RM et al. Experimental chronotherapy of mouse mammary adenocarcinoma MA13/C with docetaxel and doxorubicin as single agents and in combination. Cancer Res 2001; 61: 1996-2001.
10. Granda TG, Levi F. Tumor-based rhythms of anticancer efficacy in experimental models. Chronobiol Int 2002; 19: 21-41.
11. Innominato PF, Giacchetti S, Moreau T et al. Prediction of survival by neutropenia according to delivery schedule of oxaliplatin-5-Fluorouracil- leucovorin for metastatic colorectal cancer in a randomized international trial (EORTC 05963). Chronobiol Int 2011; 28: 586-600.
12. Coudert B, Focan C, Genet D et al. A randomized multicenter study of optimal circadian time of vinorelbine combined with chronomodulated 5-fluorouracil in pretreated metastatic breast cancer patients: EORTC trial 05971. Chronobiol Int 2008; 25: 680-96.
13. Levi F, Zidani R, Misset JL. Randomised multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancer. International Organization for Cancer Chronotherapy. Lancet 1997; 350: 681-6.
14. Buchi KN, Moore JG, Hrushesky WJ et al. Circadian rhythm of cellular proliferation in the human rectal mucosa. Gastroenterology 1991; 101: 410-5.
15. Bjarnason GA, Jordan RC, Sothern RB. Circadian variation in the expression of cell-cycle proteins in human oral epithelium. Am J Pathol 1999; 154: 613-22.
16. Rich TA, Shelton CH, III, Kirichenko A et al. Chronomodulated chemotherapy and irradiation: an idea whose time has come? Chronobiol Int 2002; 19: 191-205.
17. Haus E. Chronobiology of the mammalian response to ionizing radiation. Potential applications in oncology. Chronobiol Int 2002; 19: 77-100.
18. Shukla P, Gupta D, Bisht SS et al. Circadian variation in radiation-induced intestinal mucositis in patients with cervical carcinoma. Cancer 2010; 116: 2031-5.
19. Goyal M, Shukla P, Gupta D et al. Oral mucositis in morning vs. evening irradiated patients: a randomised prospective study. Int J Radiat Biol 2009; 85: 504-9.
20. Bjarnason GA, Mackenzie RG, Nabid A et al. Comparison of toxicity associated with early morning versus late afternoon radiotherapy in patients with head-and-neck cancer: a prospective randomized trial of the National Cancer Institute of Canada Clinical Trials Group (HN3). Int J Radiat Oncol Biol Phys 2009; 73: 166-72.
21. Fisher J, Scott C, Stevens R et al. Randomized phase III study comparing Best Supportive Care to Biafine as a prophylactic agent for radiation-induced skin toxicity for women undergoing breast irradiation: Radiation Therapy Oncology Group (RTOG) 97-13. Int J Radiat Oncol Biol Phys 2000; 48: 1307-10.
22. Pignol JP, Olivotto I, Rakovitch E et al. A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis. J Clin Oncol 2008; 26: 2085-92.
23. Mangoni M, Bisanzi S, Carozzi F et al. Association between genetic polymorphisms in the XRCC1, XRCC3, XPD, GSTM1, GSTT1, MSH2, MLH1, MSH3, and MGMT genes and radiosensitivity in breast cancer patients. Int J Radiat Oncol Biol Phys 2011; 81: 52-8.
24. Chang-Claude J, Popanda O, Tan XL et al. Association between polymorphisms in the DNA repair genes, XRCC1, APE1, and XPD and acute side effects of radiotherapy in breast cancer patients. Clin Cancer Res 2005; 11: 4802-9.
25. Ernestos B, Nikolaos P, Koulis G et al. Increased chromosomal radiosensitivity in women carrying BRCA1/BRCA2 mutations assessed with the G2 assay. Int J Radiat Oncol Biol Phys 2010; 76: 1199-205.
26. Park H, Choi DH, Noh JM et al. Acute skin toxicity in Korean breast cancer patients carrying BRCA mutations. Int J Radiat Biol, 2013; doi: 10.3109/09553002.2013.835504, Epub ahead of print.
27. Ferlay J, Shin HR, Bray F et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893-917.
28. Ragaz J, Olivotto IA, Spinelli JJ et al. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. J Natl Cancer Inst 2005; 97: 116-26.
29. Bijker N, Meijnen P, Peterse JL et al. Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853-a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. J Clin Oncol 2006; 24: 3381-7.
30. Veronesi U, Cascinelli N, Mariani L et al. Twenty-year followup of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 2002; 347: 1227-32.
31. Watson LC, Gies D, Thompson E et al. Randomized control trial: evaluating aluminum-based antiperspirant use, axilla skin toxicity, and reported quality of life in women receiving external beam radiotherapy for treatment of Stage 0, I, and II breast cancer. Int J Radiat Oncol Biol Phys 2012; 83: e29-34.